SHMT2 and metabolic dysfunction-associated steatotic liver disease: These findings suggest that SHMT2 plays a crucial role in suppressing genes involved in de novo lipogenesis, while promoting inflammation and fibrosis pathways in a diet-induced model of NAFLD.